Integer Holdings Corp

Signal Note: OrbiMed Exit from Integer Holdings (ITGR)

OrbiMed's $30M exit from ITGR—a contract manufacturer serving medtech and pharma—suggests reduced conviction in the medical device supply chain thesis, potentially reflecting concerns over customer concentration, margin pressure, or near-term revenue visibility. The concurrent holdings by Driehaus Capital and Deerfield Management indicate specialist fund convergence on ITGR, though OrbiMed's departure may signal divergent views on valuation or operational trajectory within the investor base.

Unlock full AI analysis — 14-day free trial